lilly compound tirzepatide Eli sues companies selling alternative versions of its weight loss drug Lilly releases Zepbound® (tirzepatide) single-dose

It can be used to treat conditions such as gestational diabetes, polycystic ovary syndrome, and weight gain associated with antipsychotic drugs

doi: 10.1038/s41591-018-0104-9 16 ByrneCDTargherG

Semaglutides appetite-suppressing effects could reduce the intake of important nutrients, such as iron, vitamin B12, and folate, which are all essential for red blood cell production

Third, discuss realistic expectations: dual therapy may offer incremental weight loss gains but also carries a higher risk of side effects and requires closer follow-up than monotherapy

CMS clarified that the Bridge Program cannot accept prospective prior authorizations